ONDRÚŠ, Tomáš, Martin PENICKA, Martin KOTRC, Marc VANDERHEYDEN and Josef BARTUNEK. MitraClip: Catheter-based treatment of mitral regurgitation. Cor et Vasa. Brno: Česká kardiologická společnost, 2017, vol. 59, No 1, p. "e85"-"e91", 7 pp. ISSN 0010-8650. Available from: https://dx.doi.org/10.1016/j.crvasa.2017.01.015.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name MitraClip: Catheter-based treatment of mitral regurgitation
Name in Czech MitraClip: katetrizační léčba mitrální regurgitace
Authors ONDRÚŠ, Tomáš (703 Slovakia, guarantor, belonging to the institution), Martin PENICKA (56 Belgium), Martin KOTRC (203 Czech Republic), Marc VANDERHEYDEN (56 Belgium) and Josef BARTUNEK (56 Belgium).
Edition Cor et Vasa, Brno, Česká kardiologická společnost, 2017, 0010-8650.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/17:00097417
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.crvasa.2017.01.015
UT WoS 000410029900016
Keywords in English Catheter-based treatment; MitraClip; Mitral regurgitation
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 13/3/2018 17:36.
Abstract
Mitral regurgitation (MR) is the second most prevalent heart valve disease requiring surgery. Despite the evidence of unfavourable prognosis, around half of patients with severe MR are not referred for surgery due to high per-operative risk. MitraClip (Abbott Vascular-Structural Heart, Menlo Park, California, United States) implantation is an emerging percutaneous technique with edge-to-edge MV repair inspired by the Alfieri surgery. Favourable safety profile together with improvement of functional status and decrease of MR severity in high-surgical-risk patients have been demonstrated in randomized clinical trials and “real-world” registries for both primary and secondary MR. Our own data confirmed its safety and efficacy comparing to minimally invasive MV surgery in treatment of functional MR in population with severe systolic heart failure.
PrintDisplayed: 25/7/2024 21:50